glp 1 medullary thyroid cancer The Truth About GLP-1s: Assessing the Risk of in Humans GLP-1RA and thyroid cancer: New

An additional 2 clinics offer cash-pay options for patients without coverage

The SELECT trial in non-diabetic patients with cardiovascular disease demonstrated a 20% reduction in heart attacks and strokes

doi:10.1038/s41392-024-01951-9 Uusitupa M, Khan TA, Viguiliouk E, et al

The FDA and other global regulatory bodies have approved several GLP-1 agonists for managing type 2 diabetes, such as: Semaglutide (Ozempic, Rybelsus) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) These approvals were granted after rigorous clinical trials demonstrated their efficacy and safety for glycemic control

Biomarkers to monitor for GLP-1 safety Experts consider GLP-1s safe